AAAAAA
Results: 26-38/38
Authors:
FISHER CJ
MARRA MN
PALARDY JE
MARCHBANKS CR
SCOTT RW
OPAL SM
Citation: Cj. Fisher et al., HUMAN NEUTROPHIL BACTERICIDAL PERMEABILITY-INCREASING PROTEIN REDUCESMORTALITY-RATE FROM ENDOTOXIN CHALLENGE - A PLACEBO-CONTROLLED STUDY, Critical care medicine, 22(4), 1994, pp. 553-558
Authors:
FISHER CJ
OPAL SM
Citation: Cj. Fisher et Sm. Opal, TUMOR-NECROSIS-FACTOR IN CRITICAL ILLNESS - REPLY, Critical care medicine, 22(10), 1994, pp. 1702-1703
Authors:
FISHER CJ
SLOTMAN GJ
OPAL SM
PRIBBLE JP
BONE RC
EMMANUEL G
NG D
BLOEDOW DC
CATALANO MA
FRIEDMAN B
MURE A
SHAPIRO E
Citation: Cj. Fisher et al., INITIAL EVALUATION OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF SEPSIS SYNDROME - A RANDOMIZED, OPEN-LABEL, PLACEBO-CONTROLLED MULTICENTER TRIAL, Critical care medicine, 22(1), 1994, pp. 12-21
Authors:
FISHER CJ
HILL S
MILLIS RR
Citation: Cj. Fisher et al., BENIGN LYMPH-NODE INCLUSIONS MIMICKING METASTATIC CARCINOMA, Journal of Clinical Pathology, 47(3), 1994, pp. 245-247
PLASMA-CLEARANCE (CL) OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN PATIENTS WITH SEPSIS SYNDROME
Authors:
BLOEDOW DC
PRIBBLE JP
CATALANO MA
FISHER CJ
SCHENTAG JJ
JARESKO GS
BARRIERE SL
Citation: Dc. Bloedow et al., PLASMA-CLEARANCE (CL) OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN PATIENTS WITH SEPSIS SYNDROME, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 196-196
Authors:
FISHER CJ
GILLETT CE
VOJTESEK B
BARNES DM
MILLIS RR
Citation: Cj. Fisher et al., PROBLEMS WITH P53 IMMUNOHISTOCHEMICAL STAINING - THE EFFECT OF FIXATION AND VARIATION IN THE METHODS OF EVALUATION, British Journal of Cancer, 69(1), 1994, pp. 26-31
Authors:
FLETCHER S
DARRAGH D
FAN Y
GROUNDS MD
FISHER CJ
BEILHARZ MW
Citation: S. Fletcher et al., SPECIFIC CLONING OF DNA FRAGMENTS UNIQUE TO THE DOG Y-CHROMOSOME, GENET A-BIO, 10(3-4), 1993, pp. 77-83
Authors:
BARNES DM
FISHER CJ
RASBRIDGE SA
MACGEOCH C
LANE DP
Citation: Dm. Barnes et al., THE P53 PROTEIN DETECTED BY IMMUNOHISTOCHEMICAL STAINING IS NOT ALWAYS MUTANT, Journal of cellular biochemistry, 1993, pp. 248-248
Authors:
KNAUS WA
HARRELL FE
FISHER CJ
WAGNER DP
OPAL SM
SADOFF JC
DRAPER EA
WALAWANDER CA
CONBOY K
GRASELA TH
Citation: Wa. Knaus et al., THE CLINICAL-EVALUATION OF NEW DRUGS FOR SEPSIS - A PROSPECTIVE-STUDYDESIGN BASED ON SURVIVAL ANALYSIS, JAMA, the journal of the American Medical Association, 270(10), 1993, pp. 1233-1241
Authors:
BARNES DM
DUBLIN EA
FISHER CJ
LEVISON DA
MILLIS RR
Citation: Dm. Barnes et al., IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS, Human pathology, 24(5), 1993, pp. 469-476
Authors:
FISHER CJ
BOYLE S
BURKE M
PRICE AB
Citation: Cj. Fisher et al., INTRAOPERATIVE ASSESSMENT OF NODAL STATUS IN THE SELECTION OF PATIENTS WITH BREAST-CANCER FOR AXILLARY CLEARANCE, British Journal of Surgery, 80(4), 1993, pp. 457-458
Authors:
VOJTESEK B
FISHER CJ
BARNES DM
LANE DP
Citation: B. Vojtesek et al., COMPARISON BETWEEN P53 STAINING IN TISSUE-SECTIONS AND P53 PROTEINS LEVELS MEASURED BY AN ELISA TECHNIQUE, British Journal of Cancer, 67(6), 1993, pp. 1254-1258
Authors:
LANORE JJ
DHAINAUT JF
FISHER CJ
OPAL SM
ZIMMERMAN J
NIGHTINGALE P
STEPHENS S
SCHEIN RL
PANACEK EA
VINCENT JL
FOULKE GE
WARREN EL
GARRARD C
PARK G
BODMER MW
COHEN J
VANDERLINDEN G
SADOFF JC
POCHARD F
Citation: Jj. Lanore et al., EFFECTS OF AN ANTI-TNF IGG MONOCLONAL-ANTIBODY ON LEFT-VENTRICULAR PERFORMANCE IN SEPTIC PATIENTS, The American review of respiratory disease, 147(4), 1993, pp. 202-202